High Potency Drug Market Size, Share & Trends Analysis Report By Product Type (Innovative And Generic), Dosage Form (Injectables, Oral Solids, Creams), Manufacturer Type (In-House And Outsourced). Therapeutic Area (Oncology, Hormonal Imbalance, Neurology), By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034
High Potency Drug Market Size is valued at USD 185.51 Bn in 2024 and is predicted to reach USD 520.73 Bn by the year 2034 at a 11.0% CAGR during the forecast period for 2025-2034. Drugs classified as high potency are those whose active ingredient is highly concentrated or potent and is designed to produce therapeutic effects at low dosages. Dosage forms for high-potency drugs include tablets, capsules, and liquid formulatio...
Report ID: 2505 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Pharmaceutical Contract Sales Outsourcing [CSO] Market Size, Share & Trends Analysis Report By Service (Personal Promotion (Promotional Sales Team (Dedicated Sales Team, Syndicated Sales Team), Key Account Management, Vacancy Management), Non-personal Promotion, Others), By Therapeutic Area, By Region, And by Segment Forecasts, 2025-2034
Pharmaceutical Contract Sales Outsourcing [CSO] Market Size is valued at USD 10.80 Bn in 2024 and is predicted to reach USD 25.80 Bn by the year 2034 at a 9.2% CAGR during the forecast period for 2025-2034. Pharmaceutical Contract Sales Outsourcing (CSO) refers to the practice of pharmaceutical companies partnering with external organizations to handle various aspects of their sales and marketing efforts. Due to cost reductions...
Report ID: 2063 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Psychedelic Therapeutics Market Size, Share & Trends Analysis Report, by Origin of Substance (Natural and Synthetic), Type of Psychedelic Substance (Gamma-hydroxybutyrate, Ketamine, MDMA, and Psilocybin), Target Disease Indications (Depression and Anxiety Disorders, Pain Disorders, Sleep Related Disorders and Trauma), Route of Administration, By Region, Forecasts, 2025-2034
Psychedelic Therapeutics Market Size is valued at USD 2.2 Billion in 2024 and is predicted to reach USD 9.6 Billion by the year 2034 at a 15.6 % CAGR during the forecast period for 2025-2034. Psychedelic medicines are also referred to as hallucinogenic. Psychedelic medicines are a group of substances, including chemicals, such as LSD, and plants used to treat multiple mental disorders, including resistant depression, opiate addiction, and pani...
Report ID: 1329 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
Biopharmaceutical Fermentation Market Size, Share & Trends Analysis Report By Product Type (Upstream Process, Downstream Products), By Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, Others), By End-Use, By Region, And By Segment Forecasts, 2025-2034
Global Biopharmaceutical Fermentation Market Size is valued at 10.5 Billion in 2024 and is predicted to reach 19.6 Billion by the year 2034 at an 6.6 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing emphasis of companies on creating innovative biological drugs is projected to drive the need for fermentation services and products, contributing to market growth. However, adhe...
Report ID: 1410 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Rare Kidney Diseases Market Size, Share & Trends Analysis Report By Target Indication, By Type of Molecule (Small Molecules, Biologics, By Route of administration (Oral, Intravenous, Subcutaneous, Others), By End-User, By Distribution, By Region, And By Segment Forecasts, 2025-2034
Global Rare Kidney Diseases Market Size is valued at USD 2.9 Billion in 2024 and is predicted to reach USD 8.1 Billion by the year 2034 at a 11.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The emergence of the rare kidney disease market is credited to the improved understanding and identification of these conditions, resulting in higher diagnosis rates. The increasing incidences an...
Report ID: 1414 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
PARP Inhibitors Market Size, Share & Trends Analysis Report By Product (Niraparib (Zejula), Olaparib (Lynparza), Rucaparib (Rubraca), Talazoparib (Talzenna), Veliparib, Other Pipeline Drugs), By Indication, By Region, And By Segment Forecasts, 2025-2034
Global PARP Inhibitors Market Size is valued at USD 3.8 Billion in 2024 and is predicted to reach USD 15.5 Billion by the year 2034 at a 15.2% CAGR during the forecast period for 2025-2034. Poly ADP-ribose polymerase or PARP inhibitor is a constituent that blocks the PARP enzyme in the cell. During cancer, DNA damage occurs. Inhibiting or blocking PARP helps the tumor cells in restoring their damaged part of DNA. Various forms of cancer ...
Report ID: 1169 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
iPSCs Manufacturing Services Market Size, Share & Trends Analysis Report By Application (Research Products, Drug Development & Discovery, Cellular Therapy, Toxicology Screening, Personalized Medicine, Disease Modelling, Stem Cell Banking), By End-User, By Service Type, By Region, And Segment Forecasts, 2025-2034
iPSCs Manufacturing Services Market Size is valued at USD 1.3 billion in 2024 and is predicted to reach USD 4.6 billion by the year 2034 at a 14.1 % CAGR during the forecast period for 2025-2034. Induced Pluripotent Stem Cells (iPSC) are originated from skin or blood cells. iPSCs are cells that are reprogrammed from somatic cells using different transcription factors. These cells are pluripotent, have the potential for...
Report ID: 1223 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Patient Recruitment and Retention Services Market Size, Share & Trends Analysis Report By Type (Patient Recruitment Services, Patient Retention Services), By Disease (Oncology, Infectious Disease, Cardiovascular Disease, CNS/Neurology, Endocrine/Metabolic, Hematological Disorders, Others), By Trial Phases (Phase I, Phase II, Phase III, Phase IV), By Age Group (Pediatric, Adult, Geriatrics), By End User, By Region, And By Segment Forecasts, 2025-2034.
The Patient Recruitment and Retention Services Market Size is valued at USD 4.1 Billion in 2024 and is predicted to reach USD 6.7 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034. Patient recruitment and retention is an essential service for the clinical research industry, and certain developments are expected to play a significant role in the future. Patient recruitment is one of the r...
Report ID: 1335 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
Nuclear Pharmacy Market Size, Share & Trends Analysis Report By Type (Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters), Brachytherapy Isotopes. By Application (Diagnostic Applications (SPECT Applications, PET Applications), Therapeutic Applications), By Region, And By Segment Forecasts, 2025-2034
The Nuclear Pharmacy Market Size is valued at USD 6.27 Bn in 2024 and is predicted to reach USD 17.96 Bn by the year 2034 at a 11.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The market is growing because technological developments have made it possible to diagnose and treat malignant tumours with radiopharmaceuticals. Rising government financing for nuclear medic...
Report ID: 1980 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Biopharmaceutical Excipient Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Speciality Excipients), By Type of Biologics, By Scale Of Operation, By Region, And Segment Forecasts, 2025-2034
The Biopharmaceutical Excipient Manufacturing Market Size is valued at 2.73 Billion in 2024 and is predicted to reach 4.38 Billion by the year 2034 at a 5.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Increasing need for generic drugs and pharmaceutical products is driving the biopharmaceutical excipient manufacturing market. Technological advancements in bioprocessin...
Report ID: 1197 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
Pharmaceuticals